Concerns Raised Over New mRNA Flu and COVID-19 Vaccine Trial 💉

🔬The same questions around informed consent, safety monitoring and the design of vaccine studies are being raised once again. What have we learnt from the Covid saga? Apparently very little...

🇩🇰🇪🇸A new large-scale vaccine trial in Denmark and Spain is inviting people aged 65 and over to participate in a study of mCombriax, a combination mRNA vaccine targeting both influenza and COVID. The trial is due to begin this month and could involve up to 410,000 people in Denmark.

Dr Jeanne A. Rungby, (WCH Scandinavia), is raising concerns about its design and the information provided to participants.

📍Absence of a saline placebo group
📍Reliance on registry data and questionnaires
📍Limited collection of direct clinical measurements such as blood tests
📍Safety of mRNA technology.

More at: https://www.wch-scandinavia.org/en/post/dirty-trot-in-new-vaccine-trial-offered-to-the-elderly